Literature DB >> 28495048

HLA and age of onset in myasthenia gravis.

Ernestina Santos1, Andreia Bettencourt2, Ana Martins da Silva3, Daniela Boleixa4, Dina Lopes4, Sandra Brás4, Paulo Pinho E Costa5, Carlos Lopes6, Guilherme Gonçalves7, Maria Isabel Leite8, Berta Martins da Silva2.   

Abstract

The aetiology of MG is unknown, but both genetic and environmental factors are important. Over the years association of MG with Human Leucocyte Antigens (HLA) has been described in different populations. We investigated a possible association between HLA-DRB1 alleles and age of onset in MG. One hundred and fourteen MG patients (82 females) and 282 control individuals (CP) were studied. Patients were classified according to the age of onset (early-onset <50, n = 74 and late-onset ≥ 50, n = 20). Patients with thymoma (n = 20) were analyzed separately. HLA-DRB1 and HLA-B*08 genotyping was performed using PCR-SSP methodology. HLA-DRB1*03 allele was overrepresented in the global MG. When the early-onset subgroup was considered, this association became even stronger. Regarding the late-onset subgroup, the frequency of HLA-DRB1*01 allele was higher than in the CP. For the thymoma subgroup, the HLA-DRB1*10 allele frequency was significantly higher when compared to the CP. These results have shown a strong association of HLA-DRB1*03 with MG, especially for EOMG also in our population. HLA-DRB1*01 was associated to LOMG suggesting that is a susceptibility factor for this subgroup of the disease. This study confirms a different genetic background of MG subgroups regarding age of onset.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  EOMG; HLA; LOMG; Myasthenia gravis; Thymoma MG

Mesh:

Substances:

Year:  2017        PMID: 28495048     DOI: 10.1016/j.nmd.2017.04.002

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  5 in total

Review 1.  The immunogenetics of neurological disease.

Authors:  Maneesh K Misra; Vincent Damotte; Jill A Hollenbach
Journal:  Immunology       Date:  2017-12-11       Impact factor: 7.397

Review 2.  Associations between HLA and autoimmune neurological diseases with autoantibodies.

Authors:  Sergio Muñiz-Castrillo; Alberto Vogrig; Jérôme Honnorat
Journal:  Auto Immun Highlights       Date:  2020-01-22

3.  Clinical significance of age at diagnosis among patients with thymic epithelial tumors: a population-based study.

Authors:  Mina Liu; Changlu Wang; Lanting Gao; Changxing Lv; Xiaolong Fu
Journal:  Aging (Albany NY)       Date:  2020-03-30       Impact factor: 5.682

4.  B Cell Immunophenotyping and Transcriptional Profiles of Memory B Cells in Patients with Myasthenia Gravis.

Authors:  Young Gi Min; Canaria Park; Young-Nam Kwon; Je-Young Shin; Jung-Joon Sung; Yoon-Ho Hong
Journal:  Exp Neurobiol       Date:  2019-12-31       Impact factor: 3.261

5.  Next-Generation Sequencing Identifies Extended HLA Class I and II Haplotypes Associated With Early-Onset and Late-Onset Myasthenia Gravis in Italian, Norwegian, and Swedish Populations.

Authors:  Lisa E Creary; Sridevi Gangavarapu; Stacy J Caillier; Paola Cavalcante; Rita Frangiamore; Benedicte A Lie; Mats Bengtsson; Hanne Flinstad Harbo; Susanna Brauner; Jill A Hollenbach; Jorge R Oksenberg; Pia Bernasconi; Angelina Hatlø Maniaol; Lennart Hammarström; Renato Mantegazza; Marcelo A Fernández-Viña
Journal:  Front Immunol       Date:  2021-06-07       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.